|
Adverse Effects
Citations 381-390 of 402 total displayed.
|
Past content
(since May 1998):
|
- Original Investigations
Dose Discrepancies Between the Physicians' Desk Reference and the Medical Literature, and Their Possible Role in the High Incidence of Dose-Related Adverse Drug Events
- Jay S. Cohen
Arch Intern Med 2001; 161: 957-964.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Adverse Drug Effects, Compliance, and Initial Doses of Antihypertensive Drugs Recommended by the Joint National Committee vs the Physicians' Desk Reference
- Jay S. Cohen
Arch Intern Med 2001; 161: 880-885.
[Abstract]
[Full text]
[PDF]
- Special Articles
Environmental and Drug Effects on Patients With Pacemakers and Implantable Cardioverter/Defibrillators: A Practical Guide to Patient Treatment
- Nora Goldschlager; Andrew Epstein; Paul Friedman; Eli Gang; Ryszard Krol; Brian Olshansky; for the North American Society of Pacing and Electrophysiology Practice Guideline Committee
Arch Intern Med 2001; 161: 649-655.
[Extract]
[Full text]
[PDF]
- Original Investigations
How Much Information About Adverse Effects of Medication Do Patients Want From Physicians?
- Dewey K. Ziegler; Michael C. Mosier; Maritza Buenaver; Kola Okuyemi
Arch Intern Med 2001; 161: 706-713.
[Abstract]
[Full text]
[PDF]
- Comments, Opinions, and Brief Case Reports
Granulomatous Mastitis: An Uncommon Cause of Breast Abscess
- Jacques Pouchot; Elisabeth Foucher; Marie Lino; Janine Barge; Philippe Vinceneux
Arch Intern Med 2001; 161: 611-612.
[Extract]
[Full text]
[PDF]
- Original Investigations
Toleration of High Doses of Angiotensin-Converting Enzyme Inhibitors in Patients With Chronic Heart Failure: Results From the ATLAS Trial
- Barry M. Massie; Paul W. Armstrong; John G. F. Cleland; John D. Horowitz; Milton Packer; Philip A. Poole-Wilson; Lars Rydén
Arch Intern Med 2001; 161: 165-171.
[Abstract]
[Full text]
[PDF]
- Editorials
To Err Is Human
- J. Lyle Bootman
Arch Intern Med 2000; 160: 3189.
[Extract]
[Full text]
[PDF]
- Original Investigations
Long-term Assessment of Psychological Well-being in a Randomized Placebo-Controlled Trial of Cholesterol Reduction With Pravastatin
- Ralph A. Stewart; Katrina J. Sharples; Fiona M. North; David B. Menkes; Jenny Baker; John Simes; for the LIPID Study Investigators
Arch Intern Med 2000; 160: 3144-3152.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Safety and Efficacy of Meloxicam in the Treatment of Osteoarthritis: A 12-Week, Double-blind, Multiple-Dose, Placebo-Controlled Trial
- David Yocum; Roy Fleischmann; Paul Dalgin; Jacques Caldwell; David Hall; Paul Roszko; for the Meloxicam Osteoarthritis Investigators
Arch Intern Med 2000; 160: 2947-2954.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Gastrointestinal Tolerability of the Selective Cyclooxygenase-2 (COX-2) Inhibitor Rofecoxib Compared With Nonselective COX-1 and COX-2 Inhibitors in Osteoarthritis
- Douglas J. Watson; Sean E. Harper; Peng-Liang Zhao; Hui Quan; James A. Bolognese; Thomas J. Simon
Arch Intern Med 2000; 160: 2998-3003.
[Abstract]
[Full text]
[PDF]
|
|
